Cleared Traditional

K212896 - Visible Patient Suite (FDA 510(k) Clearance)

Nov 2021
Decision
56d
Days
Class 2
Risk

K212896 is an FDA 510(k) clearance for the Visible Patient Suite. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).

Submitted by Visible Patient, Sas (Strasbourg, FR). The FDA issued a Cleared decision on November 5, 2021, 56 days after receiving the submission on September 10, 2021.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K212896 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 2021
Decision Date November 05, 2021
Days to Decision 56 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LLZ - System, Image Processing, Radiological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050